文献速递遗传性与小管间质肾病慢性肾脏病水电解质与酸碱

mtDNA致病变异可导致Gitelman样综合征

Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA.
PubMed 文献 · J Am Soc Nephrol · 2021-10-04

该研究在3个Gitelman样电解质异常家系中发现线粒体DNA(mtDNA)变异,随后在156个家系中筛查MT-TI和MT-TF基因,共发现4个mtDNA变异分布于13个家系,患者成纤维细胞显示氧化磷酸化复合物IV功能障碍,抑制复合物IV可减少NCC磷酸化及钠摄取,提示MT-TF和MT-TI致病变异可导致Gitelman样综合征。

要点

  • MT-TF和MT-TI的致病变异可导致Gitelman样综合征,应纳入不明原因Gitelman样肾小管病的基因检测范围。
  • 部分MT-TF变异家系患者还伴有进展性慢性肾脏病。
  • mtDNA变异通过氧化磷酸化复合物IV功能障碍降低NCC活性。

核心结论

  • MT-TF和MT-TI的致病变异可导致Gitelman样综合征。
  • 对不明原因Gitelman样肾小管病患者应考虑mtDNA基因检测。

研究设计与样本

  • 在3个Gitelman样电解质异常家系中鉴定mtDNA变异,并在156个家系中筛查MT-TI和MT-TF变异。
  • 评估患者成纤维细胞线粒体呼吸链功能,并在表达NCC的HEK293细胞中诱导线粒体功能障碍以评估对噻嗪敏感性22Na+转运的影响。

主要发现

  • 在13个家系中发现4个mtDNA变异:m.591C>T(n=7)、m.616T>C(n=1)、m.643A>G(n=1)位于MT-TF,m.4291T>C(n=4)位于MT-TI。
  • 除m.643A>G被归类为意义不明变异外,其余变异均被归类为致病变异。
  • 6个MT-TF变异家系的受累成员还患有进展性慢性肾脏病。
  • 患者成纤维细胞显示氧化磷酸化复合物IV功能障碍和最大线粒体呼吸能力降低。
  • 体外药物抑制复合物IV可抑制NCC磷酸化和NCC介导的钠摄取。

临床怎么用

  • 对Gitelman样综合征表型患者,尤其伴进展性慢性肾脏病且SLC12A3等基因检测阴性时,应考虑mtDNA基因检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gitelman syndrome is the most frequent hereditary salt-losing tubulopathy characterized by hypokalemic alkalosis and hypomagnesemia. Gitelman syndrome is caused by biallelic pathogenic variants in SLC12A3, encoding the Na+-Cl- cotransporter (NCC) expressed in the distal convoluted tubule. Pathogenic variants of CLCNKB, HNF1B, FXYD2, or KCNJ10 may result in the same renal phenotype of Gitelman syndrome, as they can lead to reduced NCC activity. For approximately 10 percent of patients with a Gitelman syndrome phenotype, the genotype is unknown. METHODS: We identified mitochondrial DNA (mtDNA) variants in three families with Gitelman-like electrolyte abnormalities, then investigated 156 families for variants in MT-TI and MT-TF, which encode the transfer RNAs for phenylalanine and isoleucine. Mitochondrial respiratory chain function was assessed in patient fibroblasts. Mitochondrial dysfunction was induced in NCC-expressing HEK293 cells to assess the effect on thiazide-sensitive 22Na+ transport. RESULTS: Genetic investigations revealed four mtDNA variants in 13 families: m.591C>T (n=7), m.616T>C (n=1), m.643A>G (n=1) (all in MT-TF), and m.4291T>C (n=4, in MT-TI). Variants were near homoplasmic in affected individuals. All variants were classified as pathogenic, except for m.643A>G, which was classified as a variant of uncertain significance. Importantly, affected members of six families with an MT-TF variant additionally suffered from progressive chronic kidney disease. Dysfunction of oxidative phosphorylation complex IV and reduced maximal mitochondrial respiratory capacity were found in patient fibroblasts. In vitro pharmacological inhibition of complex IV, mimicking the effect of the mtDNA variants, inhibited NCC phosphorylation and NCC-mediated sodium uptake. CONCLUSION: Pathogenic mtDNA variants in MT-TF and MT-TI can cause a Gitelman-like syndrome. Genetic investigation of mtDNA should be considered in patients with unexplained Gitelman syndrome-like tubulopathies.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Viering D, Schlingmann KP, Hureaux M, et al. Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA. J Am Soc Nephrol. 2021. PMID: 34607911. doi:10.1681/ASN.2021050596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。